Search - tctmd.com

Displaying 81 - 100 of 143

Sort: Relevancy | Date

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

Before and After PCI, Women Have Poorer Health Status Than Men

L.A. McKeown

January 28, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

Caitlin E. Cox

January 07, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 1

Todd Neale

January 03, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

Caitlin E. Cox

December 29, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Conference News AHA 2021

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Michael O'Riordan

November 13, 2021

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

AHA: More Screening Needed to Catch Myocardial Injury After Noncardiac Surgery

Yael L. Maxwell

October 04, 2021

News Daily News

Cumulative Burden of LDL Cholesterol Increases CHD Risk

Michael O'Riordan

September 23, 2021

News Daily News

Heterozygous FH Diagnosed Late, Remains Undertreated

Michael O'Riordan

September 13, 2021

News Daily News

Could an App Replace Statin Prescribing by Doctors?

Michael O'Riordan

September 08, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Conference News ESC 2021

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

Caitlin E. Cox

August 31, 2021

News Conference News ESC 2021

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Michael O'Riordan

August 30, 2021

News Daily News

Risk Stratification Before Noncardiac Surgery Won’t Catch All Myocardial Injury

Yael L. Maxwell

June 28, 2021

Advertisement

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Before and After PCI, Women Have Poorer Health Status Than Men

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

COVID-19: TCTMD’s Dispatch for January Week 1

TCTMD’s Top 10 Most Popular Stories for December 2021

British Medical Groups Express Concern About Inclisiran Rollout

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Diabetes Progression in Statin-Treated Patients: VA Data

AHA: More Screening Needed to Catch Myocardial Injury After Noncardiac Surgery

Cumulative Burden of LDL Cholesterol Increases CHD Risk

Heterozygous FH Diagnosed Late, Remains Undertreated

Could an App Replace Statin Prescribing by Doctors?

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Risk Stratification Before Noncardiac Surgery Won’t Catch All Myocardial Injury

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content